Recombinant Human DOPA Decarboxylase/DDC Protein (His Tag)(Active)
SKU: PKSH030408-50
Recombinant Human DOPA Decarboxylase/DDC Protein (His Tag)(Active)
SKU # | PKSH030408 |
Expression Host | Baculovirus-Insect Cells |
Description
Synonyms | AADC |
Species | Human |
Expression Host | Baculovirus-Insect Cells |
Sequence | Met 1-Glu 480 |
Accession | NP_000781.1 |
Calculated Molecular Weight | 55.0 kDa |
Observed Molecular Weight | 48 kDa |
Tag | C-His |
Bio-activity | Measured by its ability to convert the substrate 3, 4-dihydroxy L-phenylalanine (L-Dopa) to 3, 4-dihydroxyphenylethylamine (dopamine). The dopamine product is measured by its absorbance at 340 nm after derivatization with trinitrobenzene sulfonic acid. The specific activity is > 1000 pmoles/min/μg |
Properties
Purity | > 90 % as determined by reducing SDS-PAGE. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
Storage | Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. |
Shipping | This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C. |
Formulation | Supplied as sterile solution of 50mM Tris, 100mM NaCl, pH 8, 10% glycerol |
Reconstitution | Not Applicable |
Background
Dopa Decarboxylase (DDC), also known as AADC and Aromatic-L-amino acid decarboxylase, is a 54 kDa member of the group II decarboxylase family of proteins.It is a vitamin B6-dependent homodimeric enzyme that catalyzes the decarboxylation of both L-3,4-dihydroxyphenylalanine (L-DOPA) and L-5-hydroxytryptophan to dopamine and serotonin, respectively, which are major mammalian neurotransmitters and hormones belonging to catecholamines and indoleamines. Since L-DOPA is regularly used to treat the symptoms of Parkinson's disease, the catalytic pathway is of particular research interest. Defects of DDC are associated with severe developmental delay, oculogyric crises (OGC), as well as autosomal recessive disorder AADC deficiency, an early onset inborn error in neurotransmitter metabolism which can lead to catecholamine and serotonin deficiency.